September 15, 2006
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for our customers who have established product allocations with us. Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
From Southern District of Georgia Department of Justice
Healthcare Fraud Convictions result in $39 Million in Forfeiture, $33 Million in Fines, $27 Million in Restitution and Substantial Prison Time   LINK...

From Southern District of Texas Department of Justice
Defendant in Fake Vaccine Case Convicted  LINK...

From the CDC
More than 100 Million Doses of Influenza Vaccine Expected To Be Available This Year   LINK...

From the FDA
FDA Fines American Red Cross $4.2 Million for Failure to Meet Established Blood Safety Laws   LINK...

From the CDC
Instructions for the Use of Vaccine Information Statements  LINK...

From ZLB Behring
VIRTUE, Largest Clinical Trial of Subcutaneous Immunoglobulin Therapy, Opens to Primary Immunodeficiency Patients Across the U.S.  LINK...
FFF's New Flu Chart Now Available!

FFF Enterprises is excited to offer you our new 2006-2007 Influenza Vaccine Reference Chart. It answers many of the questions we commonly receive associated with flu vaccine administration. We think you'll find the chart a valuable resource. Click on the icon below to download a PDF version of the chart or to fill out the online form to receive a hard copy.











Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.




Let Your Voice Be Heard!
Public Meeting on Patient and Physician Concerns about Access to IVIG
The U.S. Department of Health and Human Services is inviting you to tell them about any problems you are having accessing IVIG. You can attend OR phone in! The call-in number will be provided after you register.

Date: September 28, 2006 from 10 a.m. to 5 p.m.
Location: Sheraton Crystal City Hotel, 1800 Jefferson Davis Highway, Arlington, VA 22202
Registration: https://www2.ergweb.com/projects/conferences/hhs/ or the ERG conference registration line, 781-674-7374
Purpose of the meeting: The Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation has contracted with Eastern Research Group, Inc (ERG) to develop an analysis of supply, distribution, demand, and access issues associated with IVIG. This meeting is to obtain public comment on access issues to be used in the analysis. The Town Hall meeting will accept comments from all stakeholders, but is focused on patient and physician concerns with access to IVIG including:
  1. Patients switching IVIG products due to access problems
  2. Changes in the administration location
  3. Patients receiving fewer treatments
  4. Patients receiving reduced dosages
  5. Reimbursement problems with IVIG products
  6. Patients receiving reduced dosages
  7. Health consequences for patients of any access issues
Comments: Meeting attendees can sign up on a first-come, first-served basis to present their comments (maximum of 5-minutes) via the meeting website when they register. Comments may be made in person or by phone. Commenters should focus on issues related to access to IVIG and quantify these impacts when possible. Commenters must provide their name, title, and organization (if applicable) on their registration and identify the topic area they will address. Presenters that cannot attend in person can participate via phone. If you are unable to attend in person, you should indicate at registration that you wish to participate via phone. A call-in conference number will be provided to you in your registration confirmation. Written comments are welcome from the public regardless of whether you attend the Town Hall Meeting or whether you make an oral presentation at the Town Hall Meeting. Written comments can be submitted either at the meeting, or before or after the meeting via e-mail to meetings@erg.com (subject: IVIG Meeting Comments). Or via regular mail to ATTN: IVIG Meeting, ERG, 110 Hartwell Avenue, Lexington, MA 02421. Please note that electronic submissions are preferred due to delays in receiving U.S. Postal Mail. We are able to consider only those comments received in writing and/or via email by 5 p.m. EST on October 15, 2006.

Attendees must register by September 21st.

BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. Click here to contact FFF Enterprises or call 800-843-7477.

©2006 FFF Enterprises Inc.
Top of Page